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EXPERIMENTAL SECTION 
 
Synthesis of N-formyl-4-bromo-2,6-diisopropylaniline.  Acetic anhydride (40 mL, 422.7 mmol) was cooled to 
0 °C and formic acid (20 mL, 530.1 mmol) was added via syringe over 10 minutes.  The colorless solution was allowed to 
warm to room temperature, then heated at 50 °C for 2 hours.  The solution was then allowed to cool to room temperature 
and then cooled to 0 °C.  4-bromo-2,6-diisopropylaniline was added via syringe, and the mixture was then allowed to warm 
to room temperature.  The mixture was allowed to stir for 30 minutes, then cooled to 0 °C, followed by the addition of 0 
°C H2O (ca. 300 mL), resulting in the formation of a light pink suspension.  The mixture was filtered, and the precipitate 
was washed with H2O (ca. 1 L).  The white precipitate was dried in vacuo overnight to give N-formyl-4-bromo-2,6-
diisopropylaniline (5.05 g, 76%) as a white solid.  Mixture of isomers 1H NMR (CDCl3): 1.16 [d, 3JH-H = 7 Hz, 12H, 
(Me2CH)2C6H2Br(NHCHO)], 1.18 [d, 3JH-H = 7 Hz, 12H, (Me2CH)2C6H2Br(NHCHO)], 3.04 [sept, 3JH-H = 7 Hz, 2H, 
(Me2CH)2C6H2Br(NHCHO)], 3.16 [sept, 3JH-H = 7 Hz, 2H, (Me2CH)2C6H2Br(NHCHO)], 7.21 [b, 1H, 
(Me2CH)2C6H2Br(NHCHO)], 7.28 [s, 2H, (Me2CH)2C6H2Br(NHCHO)], 7.30 [s, 2H, (Me2CH)2C6H2Br(NHCHO)], 
7.91 [d, 3JH-H = 12 Hz, 1H, (Me2CH)2C6H2Br(NHCHO)], 7.97 [d, 3JH-H = 12 Hz, 1H, (Me2CH)2C6H2Br(NHCHO)], 
8.38 [d, 3JH-H = 1 Hz, 1H, (Me2CH)2C6H2Br(NHCHO)].  Mixture of isomers 13C{1H} NMR (CDCl3): 23.5 [s, 4C, 
(Me2CH)2C6H2Br(NHCHO)], 23.5 [s, 4C, (Me2CH)2C6H2Br(NHCHO)], 28.7 [s, 2C, (Me2CH)2C6H2Br(NHCHO)], 
29.0 [s, 2C, (Me2CH)2C6H2Br(NHCHO)], 123.1 [s, 1C, (Me2CH)2C6H2Br(NHCHO)], 123.2 [s, 1C, 
(Me2CH)2C6H2Br(NHCHO)], 127.1 [s, 2C, (Me2CH)2C6H2Br(NHCHO)], 127.3 [s, 2C, 
(Me2CH)2C6H2Br(NHCHO)], 128.9 [s, 1C, (Me2CH)2C6H2Br(NHCHO)], 129.4 [s, 1C, 
(Me2CH)2C6H2Br(NHCHO)], 148.6 [s, 2C, (Me2CH)2C6H2Br(NHCHO)], 149.2 [s, 2C, 
(Me2CH)2C6H2Br(NHCHO)], 160.8 [s, 1C, (Me2CH)2C6H2Br(NHCHO)], 165.5 [s, 1C, 
(Me2CH)2C6H2Br(NHCHO)]. 
 
Spectroscopic data for 2,6-diisopropylphenylisocyanide.  1H NMR (C6D6): 1.06 [d, 3JH-H = 7 Hz, 12H, 
(Me2CH)2C6H3NC], 3.38 [sept, 3JH-H = 7 Hz, 2H, (Me2CH)2C6H3NC], 6.83 [d, 3JH-H = 8 Hz, 2H, (Me2CH)2C6H3NC], 
6.96 [m, 1H, (Me2CH)2C6H3NC].  1H NMR (CDCl3): 1.28 [d, 3JH-H = 7 Hz, 12H, (Me2CH)2C6H3NC], 3.41 [sept, 3JH-H = 
7 Hz, 2H, (Me2CH)2C6H3NC], 7.18 [d, 3JH-H = 8 Hz, 2H, (Me2CH)2C6H3NC], 7.32 [t, 3JH-H = 8 Hz, 1H, 
(Me2CH)2C6H3NC].  13C{1H} NMR (CDCl3): 22.2 [s, 4C, (Me2CH)2C6H3NC], 29.5 [s, 2C, (Me2CH)2C6H3NC], 122.9 
[s, 2C, (Me2CH)2C6H3NC], 124.0[m, 1C, (Me2CH)2C6H3NC], 129.0 [s, 1C, (Me2CH)2C6H3NC], 144.4 [s, 2C, 
(Me2CH)2C6H3NC], 169.3 [s, 2C, (Me2CH)2C6H3NC].  IR Data (ATR-IR neat liquid, cm-1): 3072 (w), 3036 (w), 2965 
(s), 2932 (m), 2873 (m), 2113 (vs) [ν(CN)], 1589 (w), 1462 (s), 1438 (m), 1386 (m), 1365 (m), 1351 (w), 1333 (w), 
1261 (m), 1182 (m), 1165 (w), 1109 (m), 1063 (m), 1045 (m), 936 (m), 799 (s), 750 (vs), 678 (s), 659 (w), 556 (w), 
424 (m).  IR Data (CH2Cl2, cm-1): νCN = 2118 (s). 
 
Synthesis of 4-phenyl-2,6-diisopropylphenylisocyanide.  A mixture of palladium(II) acetate (20 mg, 0.09 
mmol), triphenylphosphine (40 mg, 0.15 mmol), cesium carbonate (2.50 g, 7.67 mmol), phenylboronic acid (355 mg, 
2.91 mmol) and N-formyl-4-bromo-2,6-diisopropylaniline (750 mg, 2.64 mmol) was placed in an ampoule (500 mL) and 
treated with THF (80 mL) and then H2O (5 mL).  After the mixture was sparged with argon for ca. 10 minutes, the 
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ampoule was sealed and the mixture was heated to 85 °C with vigorous stirring for ca. 24 hours.  The reaction was 
allowed to cool to room temperature, followed by the addition of H2O (ca. 100 mL) and then Et2O (ca. 100 mL).  The 
layers were separated, and the organic layer was washed with saturated aqueous NaHCO3 (ca. 100 mL).  The organic layer 
was then dried with Na2SO4, filtered, and dried in vacuo to give N-formyl-4-phenyl-2,6-diisopropylaniline as an off-white 
solid of sufficient purity to be used directly for the synthesis of 4-phenyl-2,6-diisopropylphenylisocyanide as follows.  All of 
the crude N-formyl-4-phenyl-2,6-diisopropylaniline was dissolved in CH2Cl2 (ca. 50 mL) and treated with 
diisopropylamine (1.33 mL, 9.49 mmol), which was then cooled to 0 °C using an ice-water bath.  Phosphorus(V) 
oxychloride (500 µL, 5.36 mmol) was added dropwise over a period of 10 minutes.  The mixture was allowed to warm to 
room temperature, and stirred for 3 hours.  At this point, an aqueous solution of Na2CO3 (1.5 M, 50 mL, 75 mmol) was 
added, and the resulting biphasic mixture was allowed to stir overnight.  The next morning the mixture was diluted with 
H2O (ca. 50 mL) and then CH2Cl2 (ca. 100 mL), and the organic and aqueous layers were separated.  The organic layer 
was washed with saturated aqueous NaHCO3 (2 × 100 mL), dried with Na2SO4, filtered, and evaporated in vacuo.  The 
resulting solid residue was dissolved in a minimal amount of CH2Cl2, placed on top of a CH2Cl2 saturated silica plug, and 
eluted with CH2Cl2 (CNdippPh detected in eluent by short-wave UV excitation).  The eluent that contained CNdippPh 
was evaporated in vacuo.  The resulting white solid was dissolved in a minimal amount of boiling hexanes, allowed to cool 
to room temperature and then placed into a –15 °C freezer to give large colorless crystals in two batches which were 
isolated and dried in vacuo giving 4-phenyl-2,6-diisopropylphenylisocyanide (CNdippPh, first batch – 340 mg, second 
batch – 50 mg, total - 390 mg, 56%).  1H NMR (CDCl3):  1.36 [d, 3JH-H = 7 Hz, 12H, (Me2CH)2C6H2(C6H5)(NC)], 3.45 
[sept, 3JH-H = 7 Hz, 2H, (Me2CH)2C6H2(C6H5)(NC)], 7.37 [s, 2H, (Me2CH)2C6H2(C6H5)(NC)], 7.40 [tt, 3JH-H = 7 Hz,  
4JH-H = 1 Hz, 1H, (Me2CH)2C6H2(C6H5)(NC)], 7.48 [m, 2H, (Me2CH)2C6H2(C6H5)(NC)], 7.58, [m, 2H, 
(Me2CH)2C6H2(C6H5)(NC)].  13C{1H} NMR (CDCl3):  22.8 [s, 4C, (Me2CH)2C6H2(C6H5)(NC)], 30.1 [s, 2C, 
(Me2CH)2C6H2(C6H5)(NC)], 122.4, [s, 2C, (Me2CH)2C6H2(C6H5)(NC)], 123.6 [b, 1C, (Me2CH)2C6H2(C6H5)(NC)], 
127.4, [s, 2C, (Me2CH)2C6H2(C6H5)(NC)], 128.0, [s, 1C, (Me2CH)2C6H2(C6H5)(NC)], 129.0, [s, 2C, 
(Me2CH)2C6H2(C6H5)(NC)], 140.7, [s, 1C, biaryl linker C], 142.4, [s, 1C, biaryl linker C], 145.5, [s, 2C, 
(Me2CH)2C6H2(C6H5)(NC)], 169.1 [s, 1C, (Me2CH)2C6H2(C6H5)(NC)].  IR Data (ATR-IR drop casted from C6H6 
solution, cm-1): 3062 (w), 3032 (w), 2965 (s), 2930 (m), 2873 (m), 2111 (vs) [ν(CN)], 1598 (m), 1571 (w), 1494 (w), 
1464 (s), 1448 (s), 1413 (m), 1386 (m), 1365 (m), 1346 (m), 1267 (w), 1250 (w), 1165 (w), 1136 (w), 1109 (w), 1075 
(m), 1046 (w), 1027 (w), 961 (m), 945 (w), 918 (w), 883 (s), 823 (w), 762 (vs), 699 (vs), 634 (w), 609 (m), 434 (w).  
IR Data (CH2Cl2, cm-1): νCN = 2119 (s). 
 
Synthesis of 4-(4-biphenyl)-2,6-diisopropylphenylisocyanide.   A mixture of palladium(II) acetate (20 mg, 
0.09 mmol), triphenylphosphine (40 mg, 0.15 mmol), cesium carbonate (2.50 g, 7.67 mmol), 4-biphenylboronic acid 
(575 mg, 2.90 mmol) and N-formyl-4-bromo-2,6-diisopropylaniline (750 mg, 2.64 mmol) was placed in an ampoule (500 
mL) and treated with THF (80 mL) and then H2O (5 mL).  After the mixture was sparged with argon for ca. 10 minutes, 
the ampoule was sealed and the mixture was heated to 85 °C with vigorous stirring for ca. 21 hours.  The reaction was 
allowed to cool to room temperature, followed by the addition of H2O (ca. 100 mL) and then Et2O (ca. 100 mL).  The 
layers were separated, and the organic layer was washed with saturated aqueous NaHCO3 (ca. 100 mL).  The organic layer 
was then dried with Na2SO4, filtered, and dried in vacuo.  The resulting solid residue was dissolved in a minimal amount of 
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CH2Cl2, placed on top of a CH2Cl2 saturated silica plug, and eluted first with ca. 175 mL CH2Cl2, which was 
discarded, and then ca. 350 mL 80:20 CH2Cl2:MeOH, which contained N-formyl-4-(4-biphenyl)-2,6-diisopropylaniline.  
This eluent was evaporated in vacuo to give N-formyl-4-(4-biphenyl)-2,6-diisopropylaniline as an off-white solid of 
sufficient purity to be used directly for the synthesis of 4-(4-biphenyl)-2,6-diisopropylphenylisocyanide as follows.  All of 
the crude N-formyl-4-(4-biphenyl)-2,6-diisopropylaniline was dissolved in CH2Cl2 (ca. 50 mL) and treated with 
diisopropylamine (1.33 mL, 9.49 mmol), which was then cooled to 0 °C using an ice-water bath.  Phosphorus(V) 
oxychloride (350 µL, 3.76 mmol) was added dropwise over a period of 10 minutes.  The mixture was allowed to warm to 
room temperature, and stirred for 3 hours.  At this point, an aqueous solution of Na2CO3 (1.5 M, 30 mL, 45 mmol) was 
added, and the resulting biphasic mixture was allowed to stir overnight.  The next morning the mixture was diluted with 
saturated aqueous NaHCO3 (ca. 50 mL) and CH2Cl2 (ca. 50 mL), and the organic and aqueous layers were separated.  
The aqueous layer was extracted with additional CH2Cl2 (ca. 50 mL), and the combined organic extracts were dried with 
Na2SO4, filtered, and evaporated in vacuo.  The resulting solid residue was dissolved in a minimal amount of CH2Cl2, 
placed on top of a CH2Cl2 saturated silica plug, and eluted with CH2Cl2 (CNdippPhPh detected in eluent by short-wave 
UV excitation).  The eluent that contained CNdippPhPh was evaporated in vacuo.  The resulting white solid was dissolved 
in a minimal amount of boiling hexanes, allowed to cool to room temperature and then placed into a –15 °C freezer to give 
large colorless crystals which were isolated and dried in vacuo giving 4-(4-biphenyl)-2,6-diisopropylphenylisocyanide 
(CNdippPhPh, 600 mg, 67%).  1H NMR (CDCl3):  1.37 [d, 3JH-H = 7 Hz, 12H, (Me2CH)2C6H2(C6H5-C6H4)(NC)], 3.46 
[sept, 3JH-H = 7 Hz, 2H, (Me2CH)2C6H2(C6H5-C6H4)(NC)], 7.39 [tt, 3JH-H = 7 Hz,  4JH-H = 1 Hz, 1H, 
(Me2CH)2C6H2(C6H5-C6H4)(NC)], 7.42 [s, 2H, (Me2CH)2C6H2(C6H5-C6H4)(NC)], 7.49 [m, 2H, 
(Me2CH)2C6H2(C6H5-C6H4)(NC)], 7.65 [m, 4H, (Me2CH)2C6H2(C6H5-C6H4)(NC)], 7.71, [m, 2H, 
(Me2CH)2C6H2(C6H5-C6H4)(NC)].  13C{1H} NMR (CDCl3):  22.8 [s, 4C, (Me2CH)2C6H2(C6H5-C6H4)(NC)], 30.1 [s, 
2C, (Me2CH)2C6H2(C6H5-C6H4)(NC)], 122.3, [s, 2C, (Me2CH)2C6H2(C6H5-C6H4)(NC)], 123.6 [b, 1C, 
(Me2CH)2C6H2(C6H5-C6H4)(NC)], 127.2 [s, 2C, (Me2CH)2C6H2(C6H5-C6H4)(NC)], 127.7 [s, 1C, 
(Me2CH)2C6H2(C6H5-C6H4)(NC)], 127.8 [s, 2C, (Me2CH)2C6H2(C6H5-C6H4)(NC)], 127.8 [s, 2C, 
(Me2CH)2C6H2(C6H5-C6H4)(NC)], 129.0, [s, 2C, (Me2CH)2C6H2(C6H5-C6H4)(NC)], 139.6 [s, 1C, biaryl linker C], 
140.6 [s, 1C, biaryl linker C], 141.0 [s, 1C, biaryl linker C], 141.9 [s, 1C, biaryl linker C], 145.6 [s, 2C, 
(Me2CH)2C6H2(C6H5-C6H4)(NC)], 169.2 [s, 1C, (Me2CH)2C6H2(6H5-C6H4)(NC)].  IR Data (ATR-IR drop casted 
from C6H6 solution, cm-1): 3060 (w), 3030 (w), 2965 (s), 2931 (m), 2873 (m), 2112 (vs) [ν(CN)], 1601 (m), 1579 (w), 
1523 (w), 1488 (m), 1463 (m), 1398 (w), 1386 (w), 1365 (w), 1347 (w), 1268 (w), 1111 (w), 1076 (w), 1007 (w), 944 
(w), 888 (w), 839 (s), 820 (w), 764 (vs), 731 (m), 697 (s), 555 (w), 504 (w).  IR Data (CH2Cl2, cm-1): νCN = 2118 (s). 
 
Synthesis of 4-(3,5-dimethoxyphenyl)-2,6-diisopropylphenylisocyanide.   A mixture of palladium(II) 
acetate (20 mg, 0.09 mmol), triphenylphosphine (60 mg, 0.23 mmol), cesium carbonate (4.00 g, 12.28 mmol), 3,5-
dimethoxyphenylboronic acid (700 mg, 3.87 mmol) and N-formyl-4-bromo-2,6-diisopropylaniline (1.00 g, 3.52 mmol) 
was placed in an ampoule (500 mL) and treated with THF (80 mL) and then  H2O (6 mL).  After the mixture was sparged 
with argon for ca. 20 minutes, the ampoule was sealed and the mixture was heated to 85 °C with vigorous stirring for ca. 20 
hours.  The reaction was allowed to cool to room temperature, followed by the addition of H2O (ca. 100 mL) and then 
Et2O (ca. 100 mL).  The layers were separated, and the organic layer was washed with saturated aqueous NaHCO3 (ca. 
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100 mL).  The organic layer was then dried with Na2SO4, filtered, and dried in vacuo to give N-formyl-4-(3,5-
dimethoxyphenyl)-2,6-diisopropylaniline of sufficient purity to be used directly for the synthesis of 4-(3,5-
dimethoxyphenyl)-2,6-diisopropylphenylisocyanide as follows.  All of the crude N-formyl-4-(3,5-dimethoxyphenyl)-2,6-
diisopropylaniline was dissolved in CH2Cl2 (ca. 50 mL) and was treated with diisopropylamine (0.93 mL, 6.63 mmol), 
which was then cooled to 0 °C using an ice-water bath.  Phosphorus(V) oxychloride (220 µL, 2.29 mmol) was added 
dropwise over a period of 10 minutes.  The mixture was allowed to warm to room temperature, and stirred for 3 hours.  At 
this point, an aqueous solution of Na2CO3 (1.5 M, 20 mL, 30 mmol) was added, and the resulting biphasic mixture was 
allowed to stir overnight.  The next morning the mixture was diluted with H2O (ca. 50 mL) and the CH2Cl2 (ca. 40 mL), 
and the organic and aqueous layers were separated, and the latter was extracted with CH2Cl2 (2 × ca. 50 mL).  The 
combined organic extracts was dried with Na2SO4, filtered, and evaporated in vacuo to give 4-(3,5-dimethoxyphenyl)-2,6-
diisopropylphenylisocyanide (CNdippPhOMe2, 586 mg, 52%) as an off-white solid.  Colorless crystals of CNdippPhOMe2 can 
be obtained by (i) slow evaporation of a saturated solution of CNdippPhOMe2 in CH2Cl2 or (ii) dissolution of 
CNdippPhOMe2 in a minimal amount of boiling hexanes, allowing the solution to cool to room temperature and then 
placing the solution into a –15 °C freezer.  1H NMR (CDCl3):  1.32 [d, 3JH-H = 7 Hz, 12H, 
(Me2CH)2C6H2(C6H3OMe2)(NC)], 3.42 [sept, 3JH-H = 7 Hz, 2H, (Me2CH)2C6H2(C6H3OMe2)(NC)], 3.86 [s, 6H, 
(Me2CH)2C6H2(C6H3OMe2)(NC)], 6.50 [t, 3JH-H = 2 Hz, 1H, (Me2CH)2C6H2(C6H3OMe2)(NC)], 6.67 [d, 3JH-H = 2 Hz, 
2H, (Me2CH)2C6H2(C6H3OMe2)(NC)], 7.32 [s, 2H, (Me2CH)2C6H2(C6H3OMe2)(NC)].  13C{1H} NMR (CDCl3):  
22.8 [s, 4C, (Me2CH)2C6H2(C6H3OMe2)(NC)], 30.1 [s, 2C, (Me2CH)2C6H2(C6H3OMe2)(NC)], 55.6 [s, 2C, 
(Me2CH)2C6H2(C6H3OMe2)(NC)], 99.4 [s, 1C, (Me2CH)2C6H2(C6H3OMe2)(NC)], 106.0 [s, 2C, 
(Me2CH)2C6H2(C6H3OMe2)(NC)], 122.4 [s, 2C, (Me2CH)2C6H2(C6H3OMe2)(NC)], 123.8 [b, 1C, 
(Me2CH)2C6H2(C6H3OMe2)(NC)], 142.4 [s, 1C, biaryl linker C], 143.0 [s, 1C, biaryl linker C], 145.5 [s, 2C, 
(Me2CH)2C6H2(C6H3OMe2)(NC)], 161.3 [s, 2C, (Me2CH)2C6H2(C6H3OMe2)(NC)], 169.2 [s, 1C, 
(Me2CH)2C6H2(C6H3OMe2)(NC)].  IR Data (ATR-IR drop casted from C6H6 solution, cm-1): 3068 (w), 3003 (w), 2965 
(s), 2927 (m), 2873 (w), 2840 (w),  2115 (s) [ν(CN)], 1605 (vs), 1591 (vs), 1573 (w), 1463 (m), 1442 (m), 1405 (m), 
1352 (m), 1324 (m), 1257 (m), 1199 (s), 1163 (vs), 1107 (w), 1072 (m), 1043 (w), 991 (w), 947 (w), 925 (w), 905 (w), 
878 (w), 836 (m), 819 (w), 775 (w), 764 (w), 698 (w), 675 (m), 576 (w), 460 (w), 407 (w).  IR Data (CH2Cl2, cm-1): νCN 
= 2119 (s). 
 
Synthesis of 4-(3,4,5-trimethoxyphenyl)-2,6-diisopropylphenylisocyanide.  A mixture of palladium(II) 
acetate (20 mg, 0.09 mmol), triphenylphosphine (40 mg, 0.15 mmol), cesium carbonate (2.50 g, 7.67 mmol), 3,4,5-
trimethoxyphenylboronic acid (615 mg, 2.90 mmol) and N-formyl-4-bromo-2,6-diisopropylaniline (750 mg, 2.64 mmol) 
was placed in an ampoule (500 mL) and treated with THF (80 mL) and then  H2O (6 mL).  The mixture was sparged 
with argon for ca. 10 minutes, at which point the ampoule was sealed, heated to 85 °C with vigorous stirring for ca. 24 
hours.  The reaction was allowed to cool to room temperature, followed by the addition of H2O (ca. 100 mL) and then 
Et2O (ca. 100 mL).  The layers were separated, and the organic layer was washed with saturated aqueous NaHCO3 (2 × ca. 
100 mL).  The organic layer was then dried with Na2SO4, filtered, and dried in vacuo to give N-formyl-4-(3,4,5-
trimethoxyphenyl)-2,6-diisopropylaniline of sufficient purity to be used directly for the synthesis of 4-(3,4,5-
dimethoxyphenyl)-2,6-diisopropylphenylisocyanide as follows.  All of the crude N-formyl-4-(3,4,5-trimethoxyphenyl)-
 S6 
2,6-diisopropylaniline was dissolved in CH2Cl2 (ca. 50 mL) and was treated with diisopropylamine (1.33 mL, 9.49 
mmol), which was then cooled to 0 °C using an ice-water bath.  Phosphorus(V) oxychloride (350 µL, 3.76 mmol) was 
added dropwise over a period of 10 minutes.  The mixture was allowed to warm to room temperature, and stirred for 3 
hours.  At this point, the solution was cooled to 0 °C using an ice-water bath and an aqueous solution of Na2CO3 (1.5 M, 
50 mL, 75 mmol) was added, and the resulting biphasic mixture was allowed to stir overnight.  The next morning the 
mixture was diluted with saturated aqueous NaHCO3 (ca. 100 mL) and then CH2Cl2 (ca. 100 mL), and the organic and 
aqueous layers were separated.  The organic layer was washed with saturated aqueous NaHCO3 (ca. 100 mL), dried with 
Na2SO4, filtered, and evaporated in vacuo.  The resulting solid residue was dissolved in a minimal amount of CH2Cl2, 
placed on top of a CH2Cl2 saturated silica plug, and eluted with CH2Cl2 (CNdippPhOMe3 detected in eluent by short-wave 
UV excitation).  The eluent that contained CNdippPhOMe3 was evaporated in vacuo.  The resulting white solid was 
dissolved in a minimal amount of boiling hexanes, allowed to cool to room temperature and then placed into a –15 °C 
freezer to give large colorless crystals which were isolated and dried in vacuo giving 4-(3,4,5-dimethoxyphenyl)-2,6-
diisopropylphenylisocyanide (CNdippPhOMe3, 590 mg, 63%).  1H NMR (CDCl3):  1.34 [d, 3JH-H = 7 Hz, 12H, 
(Me2CH)2C6H2(C6H2OMe3)(NC)], 3.43 [sept, 3JH-H = 7 Hz, 2H, (Me2CH)2C6H2(C6H2OMe3)(NC)], 3.90 [s, 3H, 
(Me2CH)2C6H2(C6H2OMe3)(NC)], 3.94 [s, 6H, (Me2CH)2C6H2(C6H2OMe3)(NC)], 6.71 [s, 2H, 
(Me2CH)2C6H2(C6H2OMe3)(NC)], 7.29 [s, 2H, (Me2CH)2C6H2(C6H2OMe3)(NC)].  13C{1H} NMR (CDCl3):  22.7 [s, 
4C, (Me2CH)2C6H2(C6H2OMe3)(NC)], 30.1 [s, 2C, (Me2CH)2C6H2(C6H2OMe3)(NC)], 56.4 [s, 2C, 
(Me2CH)2C6H2(C6H2OMe3)(NC)], 61.1 [s, 1C, (Me2CH)2C6H2(C6H2OMe3)(NC)], 104.9 [s, 2C, 
(Me2CH)2C6H2(C6H2OMe3)(NC)], 122.3 [s, 2C, (Me2CH)2C6H2(C6H2OMe3)(NC)], 123.5 [b, 1C, 
(Me2CH)2C6H2(C6H2OMe3)(NC)], 136.8 [s, 1C, (Me2CH)2C6H2(C6H2OMe3)(NC)], 138.3 [s, 1C, biaryl linker C], 
142.7 [s, 1C, biaryl linker C], 145.5 [s, 2C, (Me2CH)2C6H2(C6H2OMe3)(NC)], 153.6 [s, 2C, 
(Me2CH)2C6H2(C6H2OMe3)(NC)], 169.3  [s, 1C, (Me2CH)2C6H2(C6H2OMe3)(NC)].  IR Data (ATR-IR drop casted 
from C6H6 solution, cm-1): 3001 (w), 2960 (s), 2937 (m), 2872 (m), 2828 (w),  2115 (s) [ν(CN)], 1587 (s), 1572 (s), 
1506 (s), 1462 (s), 1447 (s), 1428 (s), 1403 (w), 1380 (m), 1366 (s), 1358 (s), 1330 (w), 1270 (m), 1238 (vs), 1173 
(m), 1129 (vs), 1069 (s), 1038 (m), 1004 (s), 956 (m), 943 (m), 918 (m), 891 (m), 877 (w), 849 (m), 833 (m), 818 (m), 
802 (w), 764 (m), 740 (w), 677 (s), 669 (s), 590 (w), 528 (m), 500 (w), 468 (w).  IR Data (CH2Cl2, cm-1): νCN = 2118 
(s). 
 
Synthesis of W(CNdipp)6.  Sodium mercury amalgam, Na(Hg), was generated by adding small pieces of sodium 
(113 mg, 4.93 mmol) to mercury (ca. 10 g, 50 mmol).  THF (ca. 25 mL), 2,6-diisopropylphenylisocyanide (500 mg, 2.67 
mmol) and a suspension of WCl4(THF)2 (193 mg, 0.41 mmol) in THF (ca. 20 mL) was sequentially added to the 
amalgam.  The resulting red mixture was stirred vigorously overnight.  The next morning the mixture was evaporated to 
dryness in vacuo to give a dark-red residue.  The leftover Na(Hg) was poured out of the reaction flask, and the residue in 
the flask was extracted into benzene twice (ca. 30 mL and then ca. 10 mL).  The filtrate was concentrated to ca. one-third 
its volume while keeping the temperature of the solution at 40 °C.  The red solution was allowed to stand giving red 
crystals that were dried in vacuo to give W(CNdipp)6 (380 mg, 71%).  1H NMR (C6D6):  1.27 [d, 3JH-H = 7 Hz, 72H, 
{(Me2CH)2C6H3NC}6W], 3.72 [sept, 3JH-H = 7 Hz, 12H, {(Me2CH)2C6H3NC}6W], 6.93 – 6.99 [m, 18H, 
{(Me2CH)2C6H3NC}6W].   13C{1H} NMR (C6D6):  22.9 [s, 24C, {(Me2CH)2C6H3NC}6W], 30.5 [s, 12C, 
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{(Me2CH)2C6H3NC}6W], 123.3 [s, 12C, {(Me2CH)2C6H3NC}6W], 125.6 [s, 6C, 
{(Me2CH)2C6H3NC}6W], 129.1 [s, 6C, {(Me2CH)2C6H3NC}6W], 143.9 [s, 12C, {(Me2CH)2C6H3NC}6W], 177.3 [s, 
6C, {(Me2CH)2C6H3NC}6W].  IR Data (ATR-IR drop casted from C6H6 solution, cm-1): 3062 (w), 2961 (m), 2928 (w), 
2867 (w), 1938 (vs) [ν(CN)], 1582 (m), 1460 (w), 1431 (m), 1383 (w), 1362 (w), 1330 (w), 1249 (w), 1182 (w), 808 
(w), 793 (m), 748 (m), 665 (w), 500 (m), 470 (w). 
 
Synthesis of W(CNdippPh)6.  Sodium mercury amalgam, Na(Hg) was generated by adding small pieces of sodium 
(20 mg, 0.9 mmol) to mercury (ca. 2.6 g, 13 mmol).  To the amalgam was added a solution of CNdippPh (60 mg, 0.23 
mmol) in THF (ca. 2 mL), followed by a suspension of WCl4(THF)2 (17 mg, 0.04 mmol) in THF (ca. 2 mL), followed by 
additional THF (ca. 2 mL).  The resulting red mixture was stirred vigorously overnight.  The next morning the mixture 
was evaporated to dryness in vacuo to give a dark-red residue, which was extracted into hot (50 °C) benzene (6 × ca. 1 
mL).  Pentane was allowed to vapor diffuse into the room temperature benzene solution, giving red crystals in two 
batches, that were washed with pentane (ca. 1 mL) and dried in vacuo to give W(CNdippPh)6 (first batch – 36 mg, second 
batch – 4 mg, total – 40 mg, 65%).  1H NMR (C6D6): 1.43 [d, 3JH-H = 7 Hz, 72H, {(Me2CH)2C6H2(C6H5)(NC)}6W], 3.88 
[sept, 3JH-H = 7 Hz, 12H, {(Me2CH)2C6H2(C6H5)(NC)}6W], 7.13 [tt, 3JH-H = 7 Hz,  4JH-H = 1 Hz, 6H, 
{(Me2CH)2C6H2(C6H5)(NC)}6W], 7.22 [m, 12H, {(Me2CH)2C6H2(C6H5)(NC)}6W], 7.46 [s, 12H, 
{(Me2CH)2C6H2(C6H5)(NC)}6W], 7.53, [m, 12H, {(Me2CH)2C6H2(C6H5)(NC)}6W].  13C{1H} NMR (C6D6):  23.0 [s, 
24C, {(Me2CH)2C6H2(C6H5)(NC)}6W], 30.9 [s, 12C, {(Me2CH)2C6H2(C6H5)(NC)}6W], 122.5, [s, 12C, 
{(Me2CH)2C6H2(C6H5)(NC)}6W], 127.3 [s, 6C of Ar], 127.5 [s, 12C of Ar], 128.6 [b, 6C, 
{(Me2CH)2C6H2(C6H5)(NC)}6W], 129.0 [s, 12C of Ar], 138.8 [s, 6C of Ar], 141.9 [s, 6C of Ar], 144.5 [s, 12C of Ar], 
177.6 [s, 6C, {(Me2CH)2C6H2(C6H5)(NC)}6W].  IR Data (ATR-IR drop casted from C6H6 solution, cm-1): 3060 (w), 
3031 (w), 2960 (m), 2928 (w), 2869 (w), 1948 (vs) [ν(CN)], 1598 (m), 1452 (m), 1440 (m), 1414 (m), 1384 (w), 1363 
(w), 1328 (w), 1301 (w), 1254 (w), 1173 (w), 1076 (w), 1026 (w), 882 (m), 852 (w), 760 (m), 736 (m), 696 (m), 676 
(w), 522 (m), 476 (w). 
 
 
 
F igure  S1.   M olecular  s tructure  of  W (C N dippPh) 6 (G reen atom  = W ; blue  atom s =  N ;  b lack  atom s 
=  C ).  
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Synthesis of W(CNdippPhPh)6.  Sodium mercury amalgam, Na(Hg), was generated by adding small pieces of 
sodium (33 mg, 1.4 mmol) to mercury (ca. 4.4 g, 22 mmol).  To the amalgam was added a solution of CNdippPhPh (142 
mg, 0.42 mmol) in THF (ca. 2 mL), followed by a suspension of WCl4(THF)2 (30 mg, 0.06 mmol) in THF (ca. 2 mL), 
followed by additional THF (ca. 2 mL).  The resulting red mixture was stirred vigorously overnight.  The next afternoon 
the mixture was evaporated to dryness in vacuo to give a dark-red residue, which was extracted into benzene (6 × ca. 1 
mL).  Pentane was allowed to vapor diffuse into the benzene solution, giving red crystals, which were dissolved in C6H6 
(ca. 5 mL), filtered and lyophilized to give W(CNdippPhPh)6 (116 mg, 82%).  1H NMR (C6D6):  1.53 [d, 3JH-H = 7 Hz, 
72H, {(Me2CH)2C6H2(C6H5-C6H4)(NC)}6W], 3.97 [sept, 3JH-H = 7 Hz, 12H, {(Me2CH)2C6H2(C6H5-C6H4)(NC}6W], 
7.17 [m, 12H of Ar], 7.27 [m, 12H of Ar], 7.55 [m, 18H of Ar], 7.57 [s, 12H, {(Me2CH)2C6H2(C6H5-C6H4)(NC}6W], 
7.63, [m, 12H of Ar].  13C{1H} NMR (C6D6):  23.1 [s, 24C, {(Me2CH)2C6H2(C6H5-C6H4)(NC)}6W], 31.0 [s, 12C, 
{(Me2CH)2C6H2(C6H5-C6H4)(NC)}6W], 122.5, [s, 12C, {(Me2CH)2C6H2(C6H5-C6H4)(NC)}6W], 127.4 [s, 12C of Ar], 
127.6 [s, 12C of Ar], 128.0 [s, 12C of Ar], 128.4 [s, 6C of Ar], 128.6 [s, 6C, {(Me2CH)2C6H2(C6H5-C6H4)(NC)}6W], 
129.2 [s, 12C of Ar], 138.4 [s, 6C of Ar], 140.5 [s, 6C of Ar], 140.8 [s, 6C of Ar], 141.3 [s, 6C of Ar], 144.7 [s, 12C of Ar], 
177.6 [s, 6C, {(Me2CH)2C6H2(6H5-C6H4)(NC)}6W].  IR Data (ATR-IR drop casted from C6H6 solution, cm-1): 3059 
(w), 3027 (w), 2961 (m), 2929 (w), 2870 (w), 1940 (vs) [ν(CN)], 1598 (m), 1487 (w), 1453 (m), 1440 (m), 1384 (w), 
1363 (w), 1346 (w), 1302 (m), 1007 (w), 887 (w), 837 (m), 763 (m), 731 (m), 716 (w), 697 (m), 677 (w), 524 (m). 
 
 
F igure  S2.   M olecular  s tructure  of  W (C N dippPh Ph) 6 (G reen atom  = W ; blue  atom s =  N ;  b lack  
atom s =  C ).  
 
 
Synthesis of W(CNdippPhOMe2)6.  Sodium mercury amalgam, Na(Hg), was generated by adding small pieces of 
sodium (31 mg, 1.4 mmol) to mercury (ca. 4.7 g, 23 mmol).  To the amalgam was added a solution of CNdippPhOMe2 (122 
mg, 0.38 mmol) in THF (ca. 2 mL), followed by a suspension of WCl4(THF)2 (27 mg, 0.06 mmol) in THF (ca. 2 mL), 
followed by additional THF (ca. 2 mL).  The resulting red mixture was stirred vigorously overnight.  The next morning the 
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mixture was evaporated to dryness in vacuo to give a dark- red residue, which was extracted into benzene (6 × ca. 1 
mL).  Pentane was allowed to vapor diffuse into the benzene solution, giving red crystals that were dried in vacuo to give 
W(CNdippPhOMe2)6 (106 mg, 87%).  1H NMR (C6D6):  1.40 [d, 3JH-H = 7 Hz, 72H, 
{(Me2CH)2C6H2(C6H3OMe2)(NC)}6W], 3.35 [s, 36H, {(Me2CH)2C6H2(C6H3OMe2)(NC)}6W], 3.85 [sept, 3JH-H = 7 
Hz, 12H, {(Me2CH)2C6H2(C6H3OMe2)(NC)}6W], 6.57 [t, 3JH-H = 2 Hz, 6H, {(Me2CH)2C6H2(C6H3OMe2)(NC)}6W], 
6.93 [d, 3JH-H = 2 Hz, 12H, {(Me2CH)2C6H2(C6H3OMe2)(NC)}6W], 7.52 [s, 12H, 
{(Me2CH)2C6H2(C6H3OMe2)(NC)}6W].  13C{1H} NMR (C6D6):  23.0 [s, 24C, 
{(Me2CH)2C6H2(C6H3OMe2)(NC)}6W], 30.9 [s, 12C, {(Me2CH)2C6H2(C6H3OMe2)(NC)}6W], 55.0 [s, 12C, 
{(Me2CH)2C6H2(C6H3OMe2)(NC)}6W], 99.7 [s, 6C of Ar], 106.3 [s, 12C of Ar], 122.7 [s, 12C of Ar], 128.5 [s, 6C of 
Ar], 139.1 [s, 6C of Ar], 144.4 [s, 6C of Ar], 144.6 [s, 12C of Ar], 161.9 [s, 12C of Ar], 177.7 [s, 6C, 
{(Me2CH)2C6H2(C6H3OMe2)(NC)}6W].  IR Data (ATR-IR drop casted from C6H6 solution, cm-1): 2959 (m), 2931 (w), 
2871 (w), 2836 (w), 1949 (vs) [ν(CN)], 1594 (m), 1458 (m), 1433 (m), 1404 (w), 1358 (w), 1264 (m), 1202 (m), 1174 
(w), 1154 (m), 1066 (w), 1042 (w), 843 (w), 832 (w), 790 (m), 760 (w), 695 (m), 678 (w), 527 (m), 459 (w). 
 
   
F igure  S3.   M olecular  s tructure  of  W (C N dippPh OMe2) 6 (G reen atom  = W ; blue  atom s =  N ;  red  
atom s =  O ;  b lack  atom s =  C ).  
 
 
Synthesis of W(CNdippPhOMe3)6.  Sodium mercury amalgam, Na(Hg), was generated by adding small pieces of 
sodium (20 mg, 0.9 mmol) to mercury (ca. 6.0 g, 30 mmol).  A solution of CNdippPhOMe3 (76 mg, 0.21 mmol) in THF 
(ca. 3 mL) was added to the amalgam, followed by a suspension of WCl4(THF)2 (16 mg, 0.03 mmol) in THF (ca. 2 mL) 
and additionally THF (ca. 2 mL).  The resulting red mixture was stirred vigorously overnight.  The next morning the 
mixture was evaporated to dryness in vacuo to give a dark-red residue, which was extracted into benzene (3 × ca. 3 mL).  
Pentane was allowed to vapor diffuse into the benzene solution, giving red crystals that were washed with pentane (2 × ca. 
3 mL) and dried in vacuo to give W(CNdippPhOMe3)6 (54 mg, 71%).  1H NMR (C6D6):  1.54 [d, 3JH-H = 7 Hz, 72H, 
{(MeO)3C6H2(Me2CH)2C6H2NC}6W], 3.39 [s, 36H, {(MeO)3C6H2(Me2CH)2C6H2NC}6W], 3.89 [s, 18H, 
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{(MeO)3C6H2(Me2CH)2C6H2NC}6W], 3.98 [sept, 3JH-H = 7 Hz, 12H, {(MeO)3C6H2(Me2CH)2C6H2NC}6W], 6.79 
[s, 12H, {(MeO)3C6H2(Me2CH)2C6H2NC}6W], 7.53 [s, 12H, {(MeO)3C6H2(Me2CH)2C6H2NC}6W].  13C{1H} NMR 
(C6D6):  23.0 [s, 12C, {(MeO)3C6H2(Me2CH)2C6H2NC}6W], 31.1 [s, 6C, {(MeO)3C6H2(Me2CH)2C6H2NC}6W], 56.0 
[s, 12C, {(MeO)3C6H2(Me2CH)2C6H2NC}6W], 60.6 [s, 6C, {(MeO)3C6H2(Me2CH)2C6H2NC}6W], 106.0 [s, 12C of 
Ar], 122.7 [s, 12C of Ar], 128.6 [s, 6C of Ar], 137.7 [s, 6C of Ar], 139.5 [s, 6C of Ar], 139.7 [s, 6C of Ar], 144.5 [s, 12C of 
Ar], 154.5 [s, 12C of Ar], 177.5 [s, 6C, {(MeO)3C6H2(Me2CH)2C6H2NC}6W].  IR Data (ATR-IR drop casted from C6H6 
solution, cm-1): 2960 (m), 2934 (m), 2831 (w), 1942 (vs) [ν(CN)], 1585 (m), 1504 (m), 1458 (m), 1440 (m), 1430 
(m), 1399 (m), 1357 (w), 1270 (m), 1235 (m), 1183 (w), 1126 (s), 1068 (w), 1007 (m), 956 (w), 888 (w), 833 (m), 808 
(m), 770 (m), 741 (w), 678 (m), 525 (m), 458 (w). 
 
 
F igure  S4.   M olecular  s tructure  of  W (C N dippPh OMe3) 6 (G reen atom  = W ; blue  atom s =  N ;  red  
atom s =  O ;  b lack  atom s =  C ).  
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Table S1.  Crystal, intensity collection, and refinement data. 
 W(CNdippPh)6 W(CNdippPhPh)6a W(CNdippPhOMe2)6b W(CNdippPhOMe3)6 
lattice Triclinic Monoclinic Triclinic Monoclinic 
formula C114H126N6W C161H168N6W C150H174N6O12W C132H162N6O18W 
formula weight 1764.05 2370.85 2436.80 2304.52 
space group P–1 C2/c P–1 P21/c 
a/Å 14.456(3) 44.228(10) 13.4059(5) 13.6451(10) 
b/Å 18.045(3) 13.454(3) 17.0452(6) 20.7417(11) 
c/Å 18.803(4) 46.847(10) 17.3447(6) 21.9870(16) 
a/˚ 85.655(6) 90 62.0827(14) 90 
b/˚ 87.973(6) 111.074(3) 82.6020(16) 91.886(2) 
c/˚ 81.028(5) 90 70.1845(15) 90 
V/Å3 4829.6(15) 26012(10) 3292.6(2) 6219.4(7) 
Z 2 8 1 2 
temperature (K) 100 100 100 100 
radiation (λ, Å) 0.71073 0.71073 0.71073 0.71073 
ρ(calcd.), g cm-3 1.213 1.211 1.229 1.231 
µ(Mo Kα), mm-1 1.247 0.943 0.940 0.994 
θ max, deg. 32.438 29.170 30.508 33.971 
no. of data collected 30730 32718 19678 25166 
no. of data used 17249 21032 18992 11195 
no. of parameters 1170 1577 781 766 
R1 [I > 2σ (I)] 0.0776 0.0804 0.0464 0.0747 
wR2 [I > 2σ (I)] 0.1152 0.1411 0.1128 0.1263 
R1 [all data] 0.1583 0.1430 0.0507 0.1964 
wR2 [all data] 0.1283 0.1609 0.1173 0.1597 
GOF 1.350 1.105 1.086 1.016 
(a) Crystallized with one molecule of benzene and one molecule of pentane in the unit cell. (b) Crystallized with four 
molecules of benzene in the unit cell. 
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Extinction coefficient measurments.  An Ocean Optics 2000+ spectrophotometer using fiber optics to 
transport the light to and from a cuvette holder in a nitrogen filled glovebox was used for extinction coefficient 
measurements.  The spectrometer was controlled with the Ocean Optics SpectraSuite software package.  Stock 
solutions of 1  – 5  were made in toluene.  A 10  µL microsyringe was used to add volumes of these stock solutions 
to 2 mL of either toluene, THF or MeCN in a cuvette (the pure solvent was used as the background).  Absorption 
spectra were taken at multiple concentrations.  A plot of concentration vs. absorbance at a specific wavelength 
were fit to a linear equation; the extinction coefficients as the slope of the line. 
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Figure S5.  Absorption (solid lines) and emission (dotted lines) spectra of W(CNdipp)6 (cyan/circle), 
W(CNdippPh)6 (red/square), W(CNdippPhPh)6 (blue/diamond), W(CNdippPhOMe2)6 (black/triangle) and 
W(CNdippPhOMe3)6 (maroon/hexagram) in toluene solutions. 
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Figure S6.  Absorption (solid lines) and emission (dotted lines) spectra of W(CNdippPhOMe2)6 (black/triangle) 
and W(CNdippPhOMe3)6 (maroon/hexagram) in MeCN solutions. 
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Excitation spectra.  Excitation spectra were measured under optically dilute conditions in THF solutions.  
Emission observed at λmax. 
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Figure S7.  Corrected normalized excitation spectra (cyan, correction curve (black) supplied by the manufacturer 
shown in lower right plot), uncorrected normalized excitation spectra (red) and normalized absorption spectra 
(blue) in THF solutions. 
 
Quantum yield Measurements.  Quantum yields (φPL) were measured under optically dilute conditions by 
comparison to [Ru(bpy)3][PF6]2 in MeCN (φPL = 0.062),1,2 according to the equation: 
 
φX =
IX
IR
AR
AX
φR
ηx
2
ηR
2
, 
where AX and AR are the absorbance’s at the exciting wavelength (450 nm for all measurements), IX and IR are the 
integrated emission intensities, ηx2 and ηR2 are the squares of the refractive indices of the solvents used.  
Subscripts X and R refer to the unknown (i.e., W(CNAr)6 complexes) and reference solutions, respectively.  
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Absorption spectra were collected before and after emission spectra were taken; quantum yields were calculated 
for both A450 values to make sure there was no significant change. 
 
77K excited state decay measurements.  Measurements were made at 77K by immersing NMR tubes 
equipped with J. Young valves containing W(CNAr)6 complexes in either toluene or 2-MeTHF in a glass dewar 
filled with liquid nitrogen. 
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Figure S8.  Time-resolved luminescence traces for W(CNAr)6 complexes in toluene (left) and 2-MeTHF (right) 
glasses at 77 K (λex = 488 nm, 8 ns pulse). 
 
Table S2.  Mean lifetime values (µs) for W(CNAr)6 complexes at 77 K. 
W (C N A r) 6 T oluene 2-M eT H F 
W(CNdipp)6 5.6 9.1 
W(CNdippPh)6 6.1 10.9 
W(CNdippPhPh)6 5.2 8.3 
W(CNdippPhOMe2)6 5.3 8.2 
W(CNdippPhOMe3)6 5.6 9.1 
 
 
77K steady-state emission measurements.  Measurements were made at 77K by immersing NMR tubes 
equipped with J. Young valves containing W(CNAr)6 complexes in either toluene or 2-MeTHF in a glass dewar 
filled with liquid nitrogen.  An optical fiber was used to transport the light emitted from the sample to a Melles 
Griot CCD detector.  
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Figure S9.  Steady-state emission spectra for W(CNAr)6 complexes in toluene glasses at 77 K (λex = 488 nm). 
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Figure S10.  Steady-state emission spectra for W(CNAr)6 complexes in 2-MeTHF glasses at 77 K (λex = 488 nm). 
 
Ligand Field (LF) Analysis.   In order to determine if LF states (assuming Oh symmetry) are accessible for 
thermal activation from the MLCT excited state (3T1u), the harmonic potential surfaces of the 1T1g, 1T2g, 3T2g and 
5T2g LF states of W(CNAr)6 were estimated from spectroscopic data on W(CO)6,3 as the ligand field strength of 
ArNC is comparable to CO.4  This type of analysis was completed for [Co(OH2)6]3+, borrowing data from 
[Co(NH3)6]3+,5 in order to determine the activation energy for thermal crossing from the ground state into the 
5T2g LF state.6   
In W(CO)6, the vertical transition energies, i.e., the Franck-Condon energies, EFC, from the ground state (1A1g) 
to the 1T1g, 1T2g and 3T2g states are 29,950, 37,100 and 28,300 cm–1, respectively (these data are taken from Gray 
and Beach, Ref. 3; DFT calculations7 suggest that the ligand field states are substantially higher, which means that 
our estimates of activation barriers are lower limits).  From these data,3 the Racah parameters (B and C) and Dq, 
can be determined to be 447, 825 and 3,078 cm-1, respectively.   Therefore, EFC for the 5T2g state is:: EFC(5T2g ! 
1A1g) = 20Dq – 5B – 8C, giving ~ 52,700 cm-1.  In order to calculate minima of the potential surfaces, E0, (E0 = EFC 
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– λ and λ = ћωSa1g), Huang-Rhys parameter (S, 2.4 for the 3T2g state and 9.6 for the 5T2g state) and metal ligand 
stretching frequency (ћω, 473 cm–1),8 values have been taken from previous work.   
Based on our analysis, the lowest energy LF state is 3T1g, estimated to be ~ 27,000 cm–1 above the ground state.  
As emission occurs from a MLCT excited state with an E0 of ~ 18,300 cm–1, a lower estimate (assuming same 
distortion coordinate) of the activation energy required to reach a LF state is > 8,500 cm–1, which is much too 
large to account for the excited state decay kinetics observed.   
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Stern-Volmer analyses for reactions of *W(CNdipp)6 and *W(CNdippPhOMe2)6 with 
benzophenone and acetophenone.   
Benzophenone quenching of *W(CNdippPhOMe2)6 in THF.   
Benzophenone (39.0 mg, 0.21 mmol) was dissolved in THF (4 mL) to give a 53.5 mM solution.  
1.5 mL of a stock solution of W(CNdippPhOMe2)6 (< 5 µM) in THF was added to five separate 
cuvettes.  0, 10, 20, 30 and 40 µL of the 53.5 mM benzophenone solution were added to the five 
cuvettes, giving final concentrations of 0, 0.35, 0.70, 1.05 and 1.39 mM benzophenone, 
respectively.  Excited state lifetimes were then determined for each sample. 
 
Figure S11.  Quenching of *W(CNdippPhOMe2)6 with different concentrations of benzophenone.  
Wes-2-108 
 
 
Figure S12.  Plot of benzophenone concentration (mM) vs. (τ0/τ) – 1 for W(CNdippPhOMe2)6 to 
give a quenching rate constant of 2.7  × 109 M-1 s-1.   
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concentrations of 0, 11.4, 22.8, and 45.4 mM acetophenone, respectively.  Excited state lifetimes 
were then determined for each sample. 
 
 
Figure S13.  Quenching of *W(CNdipp)6 with different concentrations of acetophenone.  Wes-
2-140 
 
 
Figure S14.  Plot of acetophenone concentration (mM) vs. (τ0/τ) – 1 for W(CNdipp)6 to give a 
quenching rate constant of 2.2  × 108 M-1 s-1.   
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concentrations of 0, 535, 1007, and 1426 mM acetophenone, respectively.  Excited state 
lifetimes were then determined for each sample. 
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Figure S15.  Quenching of *W(CNdippPhOMe2)6 with different concentrations of acetophenone.  
Wes-2-140 
 
 
Figure S16.  Plot of acetophenone concentration (M) vs. (τ0/τ) – 1 for W(CNdippPhOMe2)6 to 
give a quenching rate constant of 2.1  × 106 M-1 s-1.   
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Cyclic  Voltammetry:  
 
 
Figure S17.  Cyclic voltammograms of W(CNdipp)6 in 0.5 M CH2Cl2 solution of [nBu4N][PF6] 
at different scan rates. 
 
 
Figure S18.  Cyclic voltammograms of W(CNdippPh)6 in 0.5 M CH2Cl2 solution of 
[nBu4N][PF6] at different scan rates. 
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Figure S19.  Cyclic voltammograms of W(CNdippPhPh)6 in 0.5 M CH2Cl2 solution of 
[nBu4N][PF6] at different scan rates. 
 
 
Figure S20.  Cyclic voltammograms of W(CNdippPhOMe2)6 in 0.5 M CH2Cl2 solution of 
[nBu4N][PF6] at different scan rates. 
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Figure S21.  Cyclic voltammograms of W(CNdippPhOMe3)6 in 0.5 M CH2Cl2 solution of 
[nBu4N][PF6] at different scan rates. 
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Figure S22.  1H NMR spectrum of CNdippPh in CDCl3. 
 
 
Figure S23.  13C{1H} NMR spectrum of CNdippPh in CDCl3. 
 
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
wes-2-031-CNbiphen-conc
CDCl3
1H
12
.7
6
2.
00
1.
83
0.
72
1.
94
1.
99
1.
35
1.
36
3.
41
3.
43
3.
44
3.
45
3.
47
3.
48
3.
50
7.
26
7.
37
7.
39
7.
40
7.
42
7.
46
7.
46
7.
48
7.
48
7.
48
7.
49
7.
50
7.
57
7.
57
7.
57
7.
58
7.
59
7.
59
7.
59
7.257.307.357.407.457.507.557.60
7.
26
7.
37
7.
39
7.
40
7.
42
7.
46
7.
46
7.
48
7.
48
7.
48
7.
49
7.
50
7.
57
7.
57
7.
57
7.
58
7.
59
7.
59
7.
59
0102030405060708090100110120130140150160170180
wes-2-031-CNbiphen-conc
CDCl3
13C{1H}
22
.7
9
30
.0
8
76
.9
1
77
.1
6
77
.4
1
12
2.
37
12
3.
58
12
7.
39
12
8.
01
12
9.
00
14
0.
72
14
2.
41
14
5.
48
16
9.
14
122123124125126127128129130
12
2.
37
12
3.
58
12
7.
39
12
8.
01
12
9.
00
 S24 
 
Figure S24.  HSQC NMR spectrum of CNdippPh in CDCl3. 
 
 
Figure S25.  1H NMR spectrum of CNdippPhPh in CDCl3. 
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Figure S26.  13C{1H} NMR spectrum of CNdippPhPh in CDCl3. 
 
 
Figure S27.  HSQC NMR spectrum of CNdippPhPh in CDCl3. 
 
0102030405060708090100110120130140150160170180
wes-2-063x-terphenNC
CDCl3
terphenylNC
22
.8
3
30
.1
2
76
.9
1
77
.1
6
77
.4
1
12
2.
26
12
3.
63
12
7.
21
12
7.
68
12
7.
75
12
7.
78
12
9.
02
13
9.
58
14
0.
62
14
0.
97
14
1.
92
14
5.
58
16
9.
21
122.5123.5124.5125.5126.5127.5128.5129.5
12
2.
26
12
3.
63
12
7.
21
12
7.
68
12
7.
75
12
7.
78
12
9.
02
6.66.76.86.97.07.17.27.37.47.57.67.77.87.98.08.18.28.38.48.5
110
115
120
125
130
135
140
145
150
155
f1
 (
pp
m
)
wes-2-031-CNterphenyl
CDCl3
HSQC
 S26 
 
Figure S28.  1H NMR spectrum of CNdippPhOMe2 in CDCl3. 
 
 
Figure S29.  13C{1H} NMR spectrum of CNdippPhOMe2 in CDCl3. 
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Figure S30.  1H NMR spectrum of CNdippPhOMe3 in CDCl3. 
 
 
Figure S31.  13C{1H} NMR spectrum of CNdippPhOMe3 in CDCl3. 
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Figure S32.  HSQC NMR spectrum of CNdippPhOMe3 in CDCl3. 
 
 
Figure S33. 1H NMR spectrum of W(CNdipp)6 in C6D6. 
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Figure S34. 13C{1H} NMR spectrum of W(CNdipp)6 in C6D6. 
 
 
Figure S35. 1H NMR spectrum of W(CNdippPh)6 in C6D6. 
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Figure S36. 13C{1H} NMR spectrum of W(CNdippPh)6 in C6D6. 
 
 
Figure S37. 1H NMR spectrum of W(CNdippPhPh)6 in C6D6. 
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Figure S38. 13C{1H} NMR spectrum of W(CNdippPhPh)6 in C6D6. 
 
 
Figure S39. 1H NMR spectrum of W(CNdippPhOMe2)6 in C6D6. 
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Figure S40. 13C{1H} NMR spectrum of W(CNdippPhOMe2)6 in C6D6. 
 
 
Figure S41. 1H NMR spectrum of W(CNdippPhOMe3)6 in C6D6. 
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Figure S42. 13C{1H} NMR spectrum of W(CNdippPhOMe3)6 in C6D6. 
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